873394

AstraZeneca Pharmaceuticals LP — FEI 2518137

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 7, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Wilmington, DE (United States)

Additional Details

Sponsor, Contract Research Organization